The clinically organ-confined adenocarcinoma of the prostate: Natural history, selection criteria for radical prostatectomy and prognostic factors based on long-term follow-up
Dr. Hans-Peter Schmid has addressed in this monograph the basic dilemmas surrounding prostate cancer. These dilemmas include the 40 % histologic incidence of invasive cancer in men in comparison to a 3 % death rate, the extraordinary slow doubling time of four to five years for untreated early clini...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Heidelberg
Steinkopff
1994
|
| Schriftenreihe: | Fortschritte der Urologie und Nephrologie
28 |
| Schlagworte: | |
| Online-Zugang: | UBR01 URL des Erstveröffentlichers |
| Zusammenfassung: | Dr. Hans-Peter Schmid has addressed in this monograph the basic dilemmas surrounding prostate cancer. These dilemmas include the 40 % histologic incidence of invasive cancer in men in comparison to a 3 % death rate, the extraordinary slow doubling time of four to five years for untreated early clinical stages (T1 and T2 cancers), the limited life span of even healthy men over 70 years of age, and the national and international debates of how to treat this cancer. It is important, however, to recognize that despite these uncertainties, prostate cancer is probably the most predictive of all human solid tumors. Dr. Schmid has addressed the basis for much of this predictability in this monograph. The level of serum PSA and its rate of increase in the untreated patient with a prostate size of less than 50 grams is undoub tedly the most useful of all measurements in predicting volume and grade of the cancer, but it is closely followed by assessment of the extent and percent of grade 4 and 5 cancer in six systematic, spatially separated biopsies. Estimating the amount of suspected cancer on digital rectal examination by assigning a clinical stage is useful, but far less quantitative than PSA and systematic biopsies. The Basel series in this monograph adds strong support to these basic concepts. April 1994 ThomasA. Stamey, M. D. Professor and Chairman Department of Urology Stanford University School of Medicine Stanford, California, USA v Contents Preface. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . V I. 1 Introduction and overview . . . . . . . . . . . . . . . . . . . . . . . . . . |
| Beschreibung: | 1 Online-Ressource (VIII, 74 p) |
| ISBN: | 9783642854309 |
| DOI: | 10.1007/978-3-642-85430-9 |
Internformat
MARC
| LEADER | 00000nmm a2200000zcb4500 | ||
|---|---|---|---|
| 001 | BV046147269 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 190905s1994 |||| o||u| ||||||eng d | ||
| 020 | |a 9783642854309 |9 978-3-642-85430-9 | ||
| 024 | 7 | |a 10.1007/978-3-642-85430-9 |2 doi | |
| 035 | |a (ZDB-2-SME)978-3-642-85430-9 | ||
| 035 | |a (OCoLC)1119025469 | ||
| 035 | |a (DE-599)BVBBV046147269 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 | ||
| 082 | 0 | |a 616.6 |2 23 | |
| 100 | 1 | |a Schmid, Hans-Peter |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a The clinically organ-confined adenocarcinoma of the prostate |b Natural history, selection criteria for radical prostatectomy and prognostic factors based on long-term follow-up |c by Hans-Peter Schmid |
| 264 | 1 | |a Heidelberg |b Steinkopff |c 1994 | |
| 300 | |a 1 Online-Ressource (VIII, 74 p) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Fortschritte der Urologie und Nephrologie |v 28 | |
| 520 | |a Dr. Hans-Peter Schmid has addressed in this monograph the basic dilemmas surrounding prostate cancer. These dilemmas include the 40 % histologic incidence of invasive cancer in men in comparison to a 3 % death rate, the extraordinary slow doubling time of four to five years for untreated early clinical stages (T1 and T2 cancers), the limited life span of even healthy men over 70 years of age, and the national and international debates of how to treat this cancer. It is important, however, to recognize that despite these uncertainties, prostate cancer is probably the most predictive of all human solid tumors. Dr. Schmid has addressed the basis for much of this predictability in this monograph. The level of serum PSA and its rate of increase in the untreated patient with a prostate size of less than 50 grams is undoub tedly the most useful of all measurements in predicting volume and grade of the cancer, but it is closely followed by assessment of the extent and percent of grade 4 and 5 cancer in six systematic, spatially separated biopsies. Estimating the amount of suspected cancer on digital rectal examination by assigning a clinical stage is useful, but far less quantitative than PSA and systematic biopsies. The Basel series in this monograph adds strong support to these basic concepts. April 1994 ThomasA. Stamey, M. D. Professor and Chairman Department of Urology Stanford University School of Medicine Stanford, California, USA v Contents Preface. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . V I. 1 Introduction and overview . . . . . . . . . . . . . . . . . . . . . . . . . . | ||
| 650 | 4 | |a Urology | |
| 650 | 4 | |a Internal Medicine | |
| 650 | 4 | |a Urology | |
| 650 | 4 | |a Internal medicine | |
| 650 | 0 | 7 | |a Prostatakrebs |0 (DE-588)4047511-6 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Prostatakrebs |0 (DE-588)4047511-6 |D s |
| 689 | 0 | |5 DE-604 | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783798509986 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783642854316 |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-3-642-85430-9 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-2-SME | ||
| 940 | 1 | |q ZDB-2-SME_1990/2004 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-031527454 | ||
| 966 | e | |u https://doi.org/10.1007/978-3-642-85430-9 |l UBR01 |p ZDB-2-SME |q ZDB-2-SME_1990/2004 |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804180486410469376 |
|---|---|
| any_adam_object | |
| author | Schmid, Hans-Peter |
| author_facet | Schmid, Hans-Peter |
| author_role | aut |
| author_sort | Schmid, Hans-Peter |
| author_variant | h p s hps |
| building | Verbundindex |
| bvnumber | BV046147269 |
| collection | ZDB-2-SME |
| ctrlnum | (ZDB-2-SME)978-3-642-85430-9 (OCoLC)1119025469 (DE-599)BVBBV046147269 |
| dewey-full | 616.6 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.6 |
| dewey-search | 616.6 |
| dewey-sort | 3616.6 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| doi_str_mv | 10.1007/978-3-642-85430-9 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03386nmm a2200469zcb4500</leader><controlfield tag="001">BV046147269</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">190905s1994 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783642854309</subfield><subfield code="9">978-3-642-85430-9</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-3-642-85430-9</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-SME)978-3-642-85430-9</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1119025469</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV046147269</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.6</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Schmid, Hans-Peter</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">The clinically organ-confined adenocarcinoma of the prostate</subfield><subfield code="b">Natural history, selection criteria for radical prostatectomy and prognostic factors based on long-term follow-up</subfield><subfield code="c">by Hans-Peter Schmid</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Heidelberg</subfield><subfield code="b">Steinkopff</subfield><subfield code="c">1994</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (VIII, 74 p)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Fortschritte der Urologie und Nephrologie</subfield><subfield code="v">28</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Dr. Hans-Peter Schmid has addressed in this monograph the basic dilemmas surrounding prostate cancer. These dilemmas include the 40 % histologic incidence of invasive cancer in men in comparison to a 3 % death rate, the extraordinary slow doubling time of four to five years for untreated early clinical stages (T1 and T2 cancers), the limited life span of even healthy men over 70 years of age, and the national and international debates of how to treat this cancer. It is important, however, to recognize that despite these uncertainties, prostate cancer is probably the most predictive of all human solid tumors. Dr. Schmid has addressed the basis for much of this predictability in this monograph. The level of serum PSA and its rate of increase in the untreated patient with a prostate size of less than 50 grams is undoub tedly the most useful of all measurements in predicting volume and grade of the cancer, but it is closely followed by assessment of the extent and percent of grade 4 and 5 cancer in six systematic, spatially separated biopsies. Estimating the amount of suspected cancer on digital rectal examination by assigning a clinical stage is useful, but far less quantitative than PSA and systematic biopsies. The Basel series in this monograph adds strong support to these basic concepts. April 1994 ThomasA. Stamey, M. D. Professor and Chairman Department of Urology Stanford University School of Medicine Stanford, California, USA v Contents Preface. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . V I. 1 Introduction and overview . . . . . . . . . . . . . . . . . . . . . . . . . .</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Urology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Internal Medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Urology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Internal medicine</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Prostatakrebs</subfield><subfield code="0">(DE-588)4047511-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Prostatakrebs</subfield><subfield code="0">(DE-588)4047511-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783798509986</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783642854316</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-3-642-85430-9</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SME</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-SME_1990/2004</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-031527454</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-3-642-85430-9</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-SME</subfield><subfield code="q">ZDB-2-SME_1990/2004</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV046147269 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T08:36:31Z |
| institution | BVB |
| isbn | 9783642854309 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-031527454 |
| oclc_num | 1119025469 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | 1 Online-Ressource (VIII, 74 p) |
| psigel | ZDB-2-SME ZDB-2-SME_1990/2004 ZDB-2-SME ZDB-2-SME_1990/2004 |
| publishDate | 1994 |
| publishDateSearch | 1994 |
| publishDateSort | 1994 |
| publisher | Steinkopff |
| record_format | marc |
| series2 | Fortschritte der Urologie und Nephrologie |
| spelling | Schmid, Hans-Peter Verfasser aut The clinically organ-confined adenocarcinoma of the prostate Natural history, selection criteria for radical prostatectomy and prognostic factors based on long-term follow-up by Hans-Peter Schmid Heidelberg Steinkopff 1994 1 Online-Ressource (VIII, 74 p) txt rdacontent c rdamedia cr rdacarrier Fortschritte der Urologie und Nephrologie 28 Dr. Hans-Peter Schmid has addressed in this monograph the basic dilemmas surrounding prostate cancer. These dilemmas include the 40 % histologic incidence of invasive cancer in men in comparison to a 3 % death rate, the extraordinary slow doubling time of four to five years for untreated early clinical stages (T1 and T2 cancers), the limited life span of even healthy men over 70 years of age, and the national and international debates of how to treat this cancer. It is important, however, to recognize that despite these uncertainties, prostate cancer is probably the most predictive of all human solid tumors. Dr. Schmid has addressed the basis for much of this predictability in this monograph. The level of serum PSA and its rate of increase in the untreated patient with a prostate size of less than 50 grams is undoub tedly the most useful of all measurements in predicting volume and grade of the cancer, but it is closely followed by assessment of the extent and percent of grade 4 and 5 cancer in six systematic, spatially separated biopsies. Estimating the amount of suspected cancer on digital rectal examination by assigning a clinical stage is useful, but far less quantitative than PSA and systematic biopsies. The Basel series in this monograph adds strong support to these basic concepts. April 1994 ThomasA. Stamey, M. D. Professor and Chairman Department of Urology Stanford University School of Medicine Stanford, California, USA v Contents Preface. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . V I. 1 Introduction and overview . . . . . . . . . . . . . . . . . . . . . . . . . . Urology Internal Medicine Internal medicine Prostatakrebs (DE-588)4047511-6 gnd rswk-swf Prostatakrebs (DE-588)4047511-6 s DE-604 Erscheint auch als Druck-Ausgabe 9783798509986 Erscheint auch als Druck-Ausgabe 9783642854316 https://doi.org/10.1007/978-3-642-85430-9 Verlag URL des Erstveröffentlichers Volltext |
| spellingShingle | Schmid, Hans-Peter The clinically organ-confined adenocarcinoma of the prostate Natural history, selection criteria for radical prostatectomy and prognostic factors based on long-term follow-up Urology Internal Medicine Internal medicine Prostatakrebs (DE-588)4047511-6 gnd |
| subject_GND | (DE-588)4047511-6 |
| title | The clinically organ-confined adenocarcinoma of the prostate Natural history, selection criteria for radical prostatectomy and prognostic factors based on long-term follow-up |
| title_auth | The clinically organ-confined adenocarcinoma of the prostate Natural history, selection criteria for radical prostatectomy and prognostic factors based on long-term follow-up |
| title_exact_search | The clinically organ-confined adenocarcinoma of the prostate Natural history, selection criteria for radical prostatectomy and prognostic factors based on long-term follow-up |
| title_full | The clinically organ-confined adenocarcinoma of the prostate Natural history, selection criteria for radical prostatectomy and prognostic factors based on long-term follow-up by Hans-Peter Schmid |
| title_fullStr | The clinically organ-confined adenocarcinoma of the prostate Natural history, selection criteria for radical prostatectomy and prognostic factors based on long-term follow-up by Hans-Peter Schmid |
| title_full_unstemmed | The clinically organ-confined adenocarcinoma of the prostate Natural history, selection criteria for radical prostatectomy and prognostic factors based on long-term follow-up by Hans-Peter Schmid |
| title_short | The clinically organ-confined adenocarcinoma of the prostate |
| title_sort | the clinically organ confined adenocarcinoma of the prostate natural history selection criteria for radical prostatectomy and prognostic factors based on long term follow up |
| title_sub | Natural history, selection criteria for radical prostatectomy and prognostic factors based on long-term follow-up |
| topic | Urology Internal Medicine Internal medicine Prostatakrebs (DE-588)4047511-6 gnd |
| topic_facet | Urology Internal Medicine Internal medicine Prostatakrebs |
| url | https://doi.org/10.1007/978-3-642-85430-9 |
| work_keys_str_mv | AT schmidhanspeter theclinicallyorganconfinedadenocarcinomaoftheprostatenaturalhistoryselectioncriteriaforradicalprostatectomyandprognosticfactorsbasedonlongtermfollowup |